abstract |
The present invention relates to a composition for preventing, improving or treating breast cancer or hormone-resistant breast cancer comprising THA (2,4,6-trihydroxyacetophenone) as an active ingredient, and more particularly, kinase 1), and thus it is expected to be useful for prevention, improvement, and treatment of breast cancer or hormone-resistant breast cancer. |